Omnicare, Inc. (OCR) Tops Q4 EPS by 2c; Guides FY12 Sales
Tweet
Share
E-mailGet Alerts OCR Hot Sheet
Price: $97.90 --0%
Financial Fact:
Income from continuing operations: 33.97M
Today's EPS Names:
OCCI, IPX, ALZN, More
Financial Fact:
Income from continuing operations: 33.97M
Today's EPS Names:
OCCI, IPX, ALZN, More
Join SI Premium – FREE
Omnicare, Inc. (NYSE: OCR) reported Q4 EPS of $0.58, $0.02 better than the analyst estimate of $0.56. Revenue for the quarter came in at $1.56 billion versus the consensus estimate of $1.52 billion.
Sees FY2012 revenue of $6.1-$6.2 billion, versus the consensus of $6.19 billion.
For earnings history and earnings-related data on Omnicare, Inc. (OCR) click here.
Sees FY2012 revenue of $6.1-$6.2 billion, versus the consensus of $6.19 billion.
For earnings history and earnings-related data on Omnicare, Inc. (OCR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
- KeyBanc gets bearish on Comcast as broadband competition intensifies
- Darden Restaurants (DRI) Reports In-Line Q1 EPS, Misses on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
